As the outbreak continues, discovering effective interventions for COVID-19 remains a important priority. Molnupiravir, an oral antiviral agent, has emerged as a promising option for treating the illness. It works by introducing errors into the COVID's genetic code, effectively preventing its copying within the body. While initially demonstrating e